课题基金 / 基金详情

Maternally Transmitted Opiate Abuse Vulnerability

Maternally Transmitted Opiate Abuse Vulnerability
母婴传播阿片类药物滥用的脆弱性
批准号:
7923990
负责人:
ELIZABETH M BYRNES
金额:
$28.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-01 至 2012-02-28

项目摘要

项目成果

ELIZABETH M BYRNES的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):许多研究表明,药物滥用的遗传性是由于遗传和环境因素。最近的研究表明,调节基因与环境之间相互作用的机制之一是表观遗传修饰。术语表观遗传学是指调节基因表达的DNA和组蛋白修饰,其从母细胞传递到子细胞或从亲本传递到子代,但不改变潜在的DNA序列。虽然很明显,表观遗传修饰可以从一代传递到下一代,但这些影响的传递机制尚未完全了解。最近的几项研究结果表明,母体环境,产前和产后,可能在表观遗传转移中发挥关键作用。迄今为止,表观遗传学在药物滥用家族模式中的作用尚未得到很好的研究。在过去十年中,青少年女性使用处方麻醉品的情况急剧增加。我们已经开发了一种雌性大鼠青少年吗啡暴露的动物模型,以研究在这个独特的发育时期使用阿片类药物的长期后果。我们的研究结果表明,除了在青春期暴露于吗啡的成年雌性大鼠的基因表达显着改变,暴露于吗啡的雌性大鼠的后代表现出增强的反应性吗啡。这些后代效应表明青少年吗啡暴露会增加下一代滥用药物的风险。该模型的一个重要方面是,青少年吗啡暴露的女性在交配前至少10天没有药物。因此,发育中的后代从未直接接触过吗啡。这意味着在后代中观察到的任何影响都是母体衍生的。本建议的目的是确定表观遗传学在青少年吗啡暴露对女性及其后代的长期影响中的作用。目前的提案将确定在青春期发育期间暴露于吗啡的女性的成年后代中的跨代表观遗传修饰(具体目标1)。它还将研究母体环境的可能变化,这些变化可能在这些后代效应的传播中发挥作用(具体目标2)。最后,我们将测试是否产后操作可以改善或预防青少年吗啡暴露的跨代影响(具体目标3)。了解药物引起的吗啡敏感性改变如何从一代传递到下一代,将有助于确定药物滥用家族模式的基本机制以及可能的干预措施。公共卫生相关性:这个项目的目标是了解在青春期接触毒品的母亲如何增加其未来后代滥用毒品的可能性。这些研究将为了解母亲因素在药物滥用家庭模式中的作用提供基础。
英文摘要
DESCRIPTION (provided by applicant): Many studies have demonstrated that the hereditary nature of drug abuse is due to both genetic and environmental factors. Recent findings demonstrate that one mechanism regulating interactions between genes and the environment are epigenetic modifications. The term epigenetics refers to DNA and histone protein modifications that regulate gene expression and which are transmitted from a mother cell to a daughter cell or from a parent to a progeny, but which do not change the underlying DNA sequence. While it is clear that epigenetic modifications can be passed from one generation to the next, the mechanisms involved in the transmission of these effects are not fully understood. Several recent findings indicate that the maternal environment, both pre- and postnatal, may play a critical role in epigenetic transfer. To date, the role of epigenetics in familial patterns of drug abuse has not been well studied. Prescription narcotics use by adolescent females has increased dramatically in the past decade. We have developed an animal model of adolescent morphine exposure in female rats to examine the long-term consequences of opiate use during this unique developmental period. Our findings demonstrate that in addition to significant alterations in gene expression in adult female rats exposed to morphine during adolescence, the offspring of adolescent-exposed females demonstrate enhanced responsiveness to morphine. These offspring effects suggest adolescent morphine exposure increases the risk of drug abuse in the next generation. One of important aspect of this model is that adolescent morphine-exposed females are drug-free for at least 10 days prior to mating. Thus, developing offspring are never directly exposed to morphine. This means that any effect observed in the offspring is maternally-derived. The purpose of the present proposal is to determine the role of epigenetics in the long-term effects of adolescent morphine exposure on both the female and her offspring. The current proposal will identify transgenerational epigenetic modifications in the adult offspring of females exposed to morphine during adolescent development (Specific Aim 1). It will also examine possible changes in the maternal environment which may play a role in the transmission of these offspring effects (Specific Aim 2). Finally, we will test whether postnatal manipulations can ameliorate or prevent the transgenerational effects of adolescent morphine exposure (Specific Aim 3). Understanding how drug-induced alterations in morphine sensitivity may be passed from one generation to the next will help identify basic mechanisms underlying familial patterns of drug abuse as well as possible interventions. PUBLIC HEALTH RELEVANCE: The goal of this project is to understand how mothers who are exposed to narcotics during adolescence increase the probability of drug abuse in their future offspring. These studies will provide a foundation for understanding the role of maternal factors in familial patterns of drug abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An Intranasal GDNF Gene Therapy for Opioid Relapse Reduction
  • 批准号:
    10154341
  • 项目类别:
  • 资助金额:
    $669.35万
  • 财政年份:
    2021
  • 负责人:
    ELIZABETH M BYRNES
  • 依托单位:
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability
  • 批准号:
    10625995
  • 项目类别:
  • 资助金额:
    $46.43万
  • 财政年份:
    2020
  • 负责人:
    ELIZABETH M BYRNES
  • 依托单位:
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability
  • 批准号:
    10226113
  • 项目类别:
  • 资助金额:
    $46.43万
  • 财政年份:
    2020
  • 负责人:
    ELIZABETH M BYRNES
  • 依托单位:
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability
  • 批准号:
    10404614
  • 项目类别:
  • 资助金额:
    $46.43万
  • 财政年份:
    2020
  • 负责人:
    ELIZABETH M BYRNES
  • 依托单位:
海外基金